Eman R. Mohammed & Ghada F. Elmasry. (2022). Development of newly synthesised quinazolinone-based CDK2 inhibitors with potent efficacy against melanoma. Taylor & Francis Group.
Chicago Style (17th ed.) CitationEman R. Mohammed and Ghada F. Elmasry. Development of Newly Synthesised Quinazolinone-based CDK2 Inhibitors with Potent Efficacy Against Melanoma. Taylor & Francis Group, 2022.
MLA (9th ed.) CitationEman R. Mohammed and Ghada F. Elmasry. Development of Newly Synthesised Quinazolinone-based CDK2 Inhibitors with Potent Efficacy Against Melanoma. Taylor & Francis Group, 2022.
Warning: These citations may not always be 100% accurate.